Correction to: Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer
- PMID: 40369660
- PMCID: PMC12077036
- DOI: 10.1186/s12957-025-03831-0
Correction to: Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer
Figures


Erratum for
-
Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer.World J Surg Oncol. 2014 May 7;12:142. doi: 10.1186/1477-7819-12-142. World J Surg Oncol. 2014. PMID: 24884516 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources